Rennsli v. Winberg

CourtDistrict Court, D. Utah
DecidedMarch 5, 2021
Docket2:20-cv-00247
StatusUnknown

This text of Rennsli v. Winberg (Rennsli v. Winberg) is published on Counsel Stack Legal Research, covering District Court, D. Utah primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rennsli v. Winberg, (D. Utah 2021).

Opinion

U . S . D IC SL TE RR ICK T COURT

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF UTAH

RENNSLI CORP., MEMORANDUM DECISION AND Plaintiff, ORDER DENYING PLAINTIFF’S MOTION TO DISMISS DEFENDANTS’ v. AMENDED COUNTERCLAIM

BRETT C. WINBERG; COMBUSTION TECHNOLOGIES USA LLC; and BOOST Case No. 2:20-cv-00247-JNP-JCB PERFORMANCE PRODUCTS INC., District Judge Jill N. Parrish Defendants.

Before the court is Plaintiff Rennsli Corporation’s (“Plaintiff”) Motion to Dismiss Defendants Brett C. Winberg, Combustion Technologies USA LLC; and Boost Performance Products Inc.’s (collectively, “Defendants”) Amended Counterclaim. ECF No. 30. Having reviewed the memoranda, the court denies Plaintiff’s Motion to Dismiss. BACKGROUND On June 14, 2011, U.S. Patent No. 7,959,693 (the “‘693 Patent”) was issued following the filing of provisional and international patent applications on November 18, 2005 and November 17, 2006, respectively. The ‘693 Patent is the result of experimentation to create a solid product that would “enhance the combustion of various types of fuel in internal combustion engines, thereby reducing knocking and increasing the amount of energy obtained from the fuels during combustion.” ECF No. 2 ¶ 10. The solid product was created through combining ferrocene, “an economical and available compound for enhancing burn rate in fuels,” with a “fuel soluble biphenyl as a carrier for the ferrocene” to make “a fuel soluble powder that could be readily measured and mixed with fuel” and could also be “pressed into pellets, or pills, that could be easily handled by consumers.” Id. ¶¶ 11–12. Plaintiff filed a patent infringement claim against Defendants on April 13, 2020, claiming infringement and induced infringement of the ‘693 Patent. ECF No. 2. Defendants answered and

asserted several affirmative defenses as well as a counterclaim seeking a declaration from the court that the ‘693 Patent is invalid “for failure to comply with one or more requirements of 35 U.S.C. §§ 102, 103, 111, 112 and 116.” ECF No. 24 ¶ 10, at 11. Other than a statement incorporating previous paragraphs in their answer, Defendants made no further allegations related to their invalidity claim. See id. ¶¶ 9–10, at 11. Plaintiff moved to dismiss Defendants’ counterclaim on June 15, 2020 for failure to state a claim under Federal Rule of Civil Procedure 12(b)(6). ECF No. 28. In response, Defendants filed their Amended Counterclaim on July 6, 2020. ECF No. 29. In their Amended Counterclaim, Defendants plead their invalidity claim through the following allegations: 10. The claims of the ‘693 Patent are anticipated and/or obvious in view of relevant prior art. For example, patent and non- patent literature publicly available prior to the conception, reduction to practice, and/or any applicable priority date for any of the claimed inventions of the ‘693 Patent disclose fuel additives and related compositions comprising ferrocene, biphenyl, and/or both ferrocene and biphenyl. Thus, the claims of the ‘693 [P]atent are invalid as either anticipated or because the claimed subject matter would have been obvious at the time the invention was made to a person having ordinary skill in the art to which said subject matter pertains. 11. Additionally, on information and belief, the composition claimed by the ‘693 Patent was in public use or on sale in the United States for more than a year prior to the date of application for patent. Thus, the ‘693 Patent should not have been granted under the statutory bar because the invention was publicly disclosed, sold, or offered for sale more than 2 one year prior to the earliest priority date of the patent application from which its ‘693 Patent issued. 12. The claims of the ‘693 Patent are invalid at least for failure to comply with one or more requirements of 35 U.S.C. §§ 102 and 103 in addition to other grounds for invalidity. 13. Pursuant to Rule 11(b)(3), the factual contentions regarding the invalidity of the ‘693 Patent are likely to have further evidentiary support after a reasonable opportunity for further investigation or discovery. Id. ¶¶ 10–13, at 11–12. Plaintiff now moves to dismiss Defendants’ Amended Counterclaim under Federal Rule of Civil Procedure 12(b)(6), arguing that Defendants’ allegations still fail to state a claim under applicable pleading standards. ECF No. 30. LEGAL STANDARD The Federal Circuit has explained that “[a] motion to dismiss for failure to state a claim upon which relief can be granted is a purely procedural question not pertaining to patent law,” and so “the law of the regional circuit” applies to such a motion. McZeal v. Sprint Nextel Corp., 501 F.3d 1354, 1355–56 (Fed. Cir. 2007). Although “the Iqbal/Twombly standard applies to ‘all civil actions,’ its applicability to patent cases has been interpreted differently among federal courts.” Robern, Inc. v. Glasscrafters, Inc., 206 F. Supp. 3d 1005, 1008 (D.N.J. 2016). This inconsistency stems from the December 2015 abrogation of Federal Rule of Civil Procedure 84 and related Form 18, which were previously used as guides for pleading patent claims and counterclaims. Before December 2015, Rule 84 provided “for a limited number of official forms which may serve as guides in pleading.” FED. R. CIV. P. 84, advisory committee’s note to 1937 adoption (citations omitted). The advisory committee later emphasized that “the forms contained in the Appendix of Forms are sufficient to withstand attack under the rules under which they [were] drawn, and that the practitioner using them may [have relied] on them to that extent” in satisfying the requirements of Federal Rule of Civil Procedure 8(a). See id., advisory committee note to 1946 3 amendment. As part of the Appendix of Forms, Form 18 provided a sample complaint for patent infringement. McZeal, 501 F.3d at 1356–57 (describing the contents of Form 18, then Form 16). “The language of Rule 84 and the Advisory Committee Notes ma[de] ‘clear that a pleading, motion, or other paper that follow[ed] one of the Official Forms [could not] be successfully

attacked.’” In re Bill of Lading Transmission & Processing Sys. Patent Litig., 681 F.3d 1323, 1334 (Fed. Cir. 2012) (citation omitted). “Therefore, before December 2015, courts generally found patent claims and counterclaims pled using Form 18 sufficient to satisfy Rule 8’s pleading requirements.” Hi-Tech Pharm., Inc. v. Hodges Consulting, Inc., 230 F. Supp. 3d 1323, 1335 (N.D. Ga. 2016) (citing McZeal, 501 F.3d at 1356–57). And “to the extent . . .

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
McZeal v. Sprint Nextel Corp.
501 F.3d 1354 (Federal Circuit, 2007)
Tyco Fire Products LP v. Victaulic Co.
777 F. Supp. 2d 893 (E.D. Pennsylvania, 2011)
Rah Color Technologies LLC v. Ricoh USA Inc.
194 F. Supp. 3d 346 (E.D. Pennsylvania, 2016)
Hi-Tech Pharmaceuticals, Inc. v. Hodges Consulting, Inc.
230 F. Supp. 3d 1323 (N.D. Georgia, 2016)
Summers Mfg. Co. v. Tri-County AG, LLC
300 F. Supp. 3d 1025 (S.D. Iowa, 2017)
R+L Carriers, Inc. v. DriverTech LLC
681 F.3d 1323 (Federal Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Rennsli v. Winberg, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rennsli-v-winberg-utd-2021.